# RADX INNOVATION FUNNEL FOR ENDOMETRIOSIS DIAGNOSTICS - COMMERCIALIZATION CENTER

> **NIH NIH N02** · VENTUREWELL · 2024 · $801,749

## Abstract

The goal of the Commercialization Center for the RADx Innovation Funnel for Endometriosis diagnostics is to provide technical, clinical, and commercialization expertise and resources while seeking to accelerate the development of point-of-care endometriosis diagnostic technologies. The Commercialization Center is a trans-NIH focused activity that requires professional services support across a range of commercialization domains to NIH translational activities. To support rapid technology development, consultants with specialized domain expertise are needed to assess and mitigate risks at various stages. The vetting and management of professional service consultants and vendors is a critical component of the parallelization effort to speed innovation.

## Key facts

- **NIH application ID:** 11219925
- **Project number:** 75N92022D00013-0-759202400002-1
- **Recipient organization:** VENTUREWELL
- **Principal Investigator:** MARK MARINO
- **Activity code:** N02 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $801,749
- **Award type:** —
- **Project period:** 2024-07-15 → 2026-03-14

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11219925

## Citation

> US National Institutes of Health, RePORTER application 11219925, RADX INNOVATION FUNNEL FOR ENDOMETRIOSIS DIAGNOSTICS - COMMERCIALIZATION CENTER (75N92022D00013-0-759202400002-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/11219925. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*